Phase IIb trial of an alpha-7 nicotinic receptor partial agonist with and without nicotine patch for withdrawal-associated cognitive deficits and tobacco abstinence

PURPOSE/BACKGROUND: The objective of this study was to determine whether a novel alpha-7 nicotinic acetylcholine receptor (nAChR) partial agonist improves cognition during nicotine withdrawal and improves abstinence rates. To do so, the effect of the alpha-7 nAChR partial agonist, encenicline, on co...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Clin Psychopharmacol
Main Authors: Schuster, Randi Melissa, Pachas, Gladys N, Stoeckel, Luke, Cather, Corinne, Nadal, Mireya, Mischoulon, David, Schoenfeld, David A., Zhang, Haiyue, Ulysse, Christine, Dodds, Elisabeth B., Sobolewski, Sara, Hudziak, Vicenta, Hanly, Ailish, Fava, Maurizio, Evins, A. Eden
Formato: Artigo
Idioma:Inglês
Publicado em: 2018
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6019566/
https://ncbi.nlm.nih.gov/pubmed/29912798
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/JCP.0000000000000919
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados